Domů › Crohnova choroba › Texas › Houston
Klinické studie Crohnova choroba v Houston, TX
17 studií pro Crohnova choroba hledá účastníky v lokalitách v Houston a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Probíhá náborFáze 3
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- Michael E. DeBakey VA Medical Center ( Site 5086), Houston
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Probíhá náborFáze 2
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · Vzdálenost 7 mi
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Probíhá náborFáze 4
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Probíhá náborFáze 2
- Houston Methodist Hospital /ID# 265533, Houston
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2/3
- Victorium Clinical Research, Houston
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- Novel Research, LLC, Bellaire · Vzdálenost 7 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Probíhá náborFáze 1
- UT MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- The University of Texas Health Science Center at Houston, Houston
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Probíhá náborFáze 4
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Probíhá náborObservační studie
- BAMC, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Probíhá nábor
- Baylor College of Medicine, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Probíhá náborObservační studie
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Probíhá náborFáze 3
- Texas Children's Hospital - Baylor - PIN, Houston
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Probíhá náborFáze 3
- Texas Children's Hospital, Houston
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- Houston Methodist Hospital, Houston
- Novel Research, LLC, Bellaire · Vzdálenost 7 mi
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Probíhá náborFáze 2
- Mirador Therapeutics Selected Site, Houston
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Probíhá náborFáze 4
- Houston Methodist Hospital, Houston
Studie Crohnova choroba v jiných městech
- New York City, NY35 studií
- Cleveland, OH19 studií
- St. Louis, MO19 studií
- Boston, MA19 studií
- Miami, FL19 studií
- Orlando, FL17 studií
- Atlanta, GA17 studií
- Tyler, TX16 studií
- San Diego, CA15 studií
- San Antonio, TX15 studií
- Los Angeles, CA15 studií
- Philadelphia, PA13 studií
Další studie v Houston
- Nemalobuněčný plicní karcinom145 studií
- Rakovina prsu126 studií
- Rakovina (všechny typy)121 studií
- Metastatický karcinom104 studií
- Kolorektální karcinom102 studií
- Rakovina vaječníků89 studií
- Akutní myeloidní leukemie85 studií
- Rakovina plic78 studií
- Rakovina prostaty76 studií
- Rakovina endometria68 studií
- Rakovina slinivky břišní61 studií
- Melanom59 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.